GlassScriptPhysician profile
Gregory P Morris
NPI 1487677480
$316.90
in general payments reported to CMS, 2019-2025
12 companies · $78.57 in 2025
The $78.57 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $116 · 2020: $13.68 · 2023: $54.29 · 2024: $54.58 · 2025: $78.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $187.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $187.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $57.01 | 2019-2023 | |
| Organon LLC | $52.74 | 2024-2025 | Jada System |
| Sumitomo Pharma America, INC. | $33.90 | 2023 | Myfembree |
| Astellas Pharma US INC | $31.98 | 2019-2024 | Veozah |
| Supernus Pharmaceuticals, INC. | $22.91 | 2025 | Qelbree |
| Sage Therapeutics, LLC | $22.91 | 2025 | Zurzuvae |
| Aspira Women'S Health INC | $20.91 | 2024 | Ova1 |
| Merck Sharp & Dohme LLC | $18.01 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.03 | 2019 | |
| Amgen INC. | $15.36 | 2019 | |
| Millicent US INC | $13.68 | 2020 | |
| Avion Pharmaceuticals | $11.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Morris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.